首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 肥胖症治療 > 臨床肥胖管理
產業/市場分類
製藥 (4450)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (167)
神經疾病 (175)
骨頭疾病治療 (40)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (316)
精神病 (80)
製藥企業 (500)
糖尿病 (157)
癌症 (837)
藥物開發 (1247)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

臨床肥胖管理

Clinical Management of Obesity

出版商 Technical Insights, Inc.
出版日期 2006年06月 商品編碼 42349
內容資訊 英文 127 pages
價格
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


臨床肥胖管理 是由出版商Technical Insights, Inc.在2006年06月所出版的。 這份英文市場調查報告書包含127 pages 價格從美金6000起跳。

簡介

隨著肥胖人口增加,第二型糖尿病及心臟病、高血壓、腦中風等健康風險隨之而來,減量療法的需求逐漸昇高。雖然有節食減肥及藥物等各式各樣的減重方法,但是考量遺傳因素及肥胖程度選擇適當的減重方法是很重要的。

專門從事多樣先進產業相關策略性調查的美國市調公司 Technical Insights, Inc. (總公司:德州),針對臨床肥胖管理進行調查分析,並將調查結果系統整理後出版報告書 "Clinical Management of Obesity" 。

本報告書內容包括:目前市場中各種減重產品及治療方法簡介、為了減重的節食減肥療法、矯正生活型態、藥物療法、肥胖手術及醫療儀器等各種應用與技術的詳細分析。內容綱要摘記如下:

第1章 實施概要

  • 調查範圍及調查方法
    • 調查範圍及區隔
    • 調查方法
  • 主要結論
    • 減重產業簡介
    • 受矚目的技術發展:企業
    • 受矚目的技術發展:大學

第2章 臨床肥胖管理:技術分析

  • 肥胖:概要
    • 定義
    • 原因及隨之而來的健康問題
  • 技術趨勢
    • 節食減肥療法與生活型態的改變
    • 藥物療法
    • 肥胖手術
    • 醫療儀器
    • 技術影響分析及未來趨勢向

第3章 技術採用之主要因素分析

  • 藥物療法
    • 促進技術發展因素
    • 阻礙技術發展因素
  • 醫療儀器
    • 促進技術發展因素
    • 阻礙技術發展因素
  • 肥胖手術
    • 促進技術發展因素
    • 阻礙技術發展因素
  • 資金分析、合作、合併
    • 企業
    • 大學與政府機關
    • 合作與合併

第4章 臨床肥満管理之進展

  • 企業技術創新:北美
    • 用來防止血清素再吸收進而達到抑制食欲目的的新減肥藥:美國
    • 妨礙大麻鹼受體的新食欲抑制劑:美國
    • 用於治療肥胖的新小分子:美國
    • 利用天然縮氨酸荷爾蒙抑制食欲及提高代謝率:美國
    • 格瑞林(Ghrelin)激素受體分子可以用在肥胖治療上:加拿大
    • 利用神經刺激技術治療慢性肥胖:美國
    • 治療肥胖用的新小分子藥:美國
    • 利用羥色胺(Hydroxytryptamine)受體促效劑治療肥胖:美國
    • 促使脂肪細胞自然凋零的新技術:美國
    • 治療疾病性肥胖的可調整及可逆的束胃法:美國
  • 企業技術創新:歐洲
    • 阻礙脂肪吸收之減肥藥的作用:英國
    • 作為新減肥藥的大麻鹼受體促效劑:英國
    • 有雙重受體促效作用之治療肥胖的單一縮氨酸類藥:丹麥
    • 以甲狀腺荷爾蒙為標的的新減肥藥:瑞典
    • 從韓國松籽中提煉出的天然食欲抑制劑:荷蘭
    • 利用胃腸消化酵素抑制劑達到減重的目的:英國
    • 誘發格瑞林(Ghrelin)特有抗體的新式疫苗治療:瑞士
  • 企業技術創新:亞太地區各國
    • 利用縮氨酸類藥物治療肥胖:澳洲
    • 預防脂質形成的肥胖治療:澳洲
    • 過氧化體增生劑:活性化受體促效劑燃燒脂肪:印度
    • 治療肥胖及相關疾病用的大麻鹼受體拮抗劑:印度
    • 減肥藥抑制澱粉酵素:印度
  • 大學技術創新:全球
    • 發現荷爾蒙給肥胖治療薬帶來希望:美國
    • 胃部荷爾蒙控制食欲:英國
    • 鈣質對減重產生影響之研究:丹麥
    • 代謝與食欲抑制間關係之研究:澳洲
    • 第二次訊息分子對飽足感產生影響之研究:英國

第5章 專利及產業資料庫

  • 專利
    • 美國的專利-2006年
    • 美國的專利-2004年至2005年
  • 主要產業中企業的資料庫
    • 企業
    • 大學

第6章 2006年FROST & SULLIVAN TECHNOLOGY AWARDS

第7章 決策支援資料庫

目錄

Abstract

Research Overview

This Frost & Sullivan research service titled Clinical Management of Obesity provides an in-depth analysis about the various commercial weight-loss products and therapies currently available in the market, and those on the verge of commercialization. In this research service, Frost & Sullivan's expert analysts thoroughly examine the following applications/technologies: diet therapies, lifestyle modifications, pharmacotherapy, bariatric surgeries, and medical devices for weight loss.

This analysis is available through our Technical Insights - Healthcare Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Frost & Sullivan Growth Partnership Service

Based on extensive and in-depth research, real-world consulting work, and new theories tested in hundreds of companies across many industries, Frost & Sullivan has evolved its Growth Partnership Services (GPS) program that provides established and emerging firms with powerful growth visions. Moving beyond token mission statements, GPS provides an actionable vision to growth consulting partners by illustrating how key intelligence and strategic research based on defined goals can guide day-to-day behavior and overall company direction. The foundation of Frost & Sullivan's GPS includes:

  • Assisting companies to reach their full potential in the core business
  • Providing growth strategies to help companies expand into related businesses
  • Preemptively redefining the core business during market turbulence
  • Applying the Frost & Sullivan framework to identify and address common mistakes resulting from misaligned corporate strategies
  • Recommending growth management strategies through continuous partnership

To maximize the potential for growth within a firm's internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programs that deliver improved market success. Frost & Sullivan's strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clients' growth.

Table of Contents

1 EXECUTIVE SUMMARY

  • Scope and Methodology
    • Scope and Segmentation
    • Methodology
  • Key Findings
    • An Overview of the Weightloss Industry
    • Noteworthy Technology Developments--Companies
    • Noteworthy Technology Developments--Universities

2 CLINICAL MANAGEMENT OF OBESITY--TECHNOLOGY ANALYSIS

  • Obesity--Overview
    • Definitions
    • Causes and Associated Health Problems
  • Technology Primer
    • Diet Therapy and Lifestyle Changes
    • Pharmacotherapy
    • Bariatric Surgery
    • Medical Devices
    • Technology Impact Analysis and Future Trends

3 TECHNOLOGY ADOPTION FACTOR ANALYSIS

  • Pharmacotherapy
    • Technology Accelerators
    • Technology Roadblocks
  • Medical Devices
    • Technology Accelerators
    • Technology Roadblocks
  • Bariatric Surgeries
    • Technology Accelerators
    • Technology Roadblocks
  • Funding Analysis; Collaborations and Mergers
    • Companies
    • Universities and Government Institutions
    • Collaborations and Mergers

4 ADVANCEMENTS IN CLINICAL MANAGEMENT OF OBESITY

  • Technology Innovations in Companies--North America
    • A Novel Antiobesity Drug Suppresses Appetite through Inhibition of Serotonin Reuptake--USA
    • A Novel Appetite Suppressant Selectively Inhibits Cannabinoid Receptors--USA
    • A Novel Small Molecule for the Treatment of Obesity--USA
    • A Natural Peptide Hormone Suppresses Appetite and Enhances Metabolic Rate--USA
    • Ghrelin Receptor Modulators Offer Potential Obesity Treatment Options--Canada
    • Neurostimulation Technique to Treat Chronic Obesity--USA
    • A Novel Small Molecule Drug to Treat Obesity--USA
    • A Unique and Selective Hydroxy Tryptamine Receptor Agonist to Treat Obesity--USA
    • A Novel and Selective Hydroxy Tryptamine Receptor Agonist for Obesity Treatment--USA
    • A Novel Technology Leads to Apoptosis of Fat Cells--USA
    • Adjustable and Reversible Gastric Banding Technique to Treat Morbid Obesity--USA
  • Technology Innovations in Companies--Europe
    • Antiobesity Drug Works by Blocking Fat Absorption--UK
    • Potent and Selective Cannabinoid Receptor Antagonists as Novel Antiobesity Agents--UK
    • A Novel Single Peptide Drug with a Dual Receptor Agonist Action to Treat Obesity--Denmark
    • A Novel Antiobesity Drug Targets Thyroid Hormone Receptors--Sweden
    • A Natural Appetite Suppressant from Korean Pine Nuts--Netherlands
    • A Unique Gastro Intestinal Lipase Inhibitor Aids Weight Loss--UK
    • A Novel Vaccine Treats Obesity by Induction of Ghrelin Specific Antibodies--Switzerland
  • Technology Innovations in Companies--APAC
    • A Novel Peptide-Based Drug to Treat Obesity--Australia
    • Potential Obesity Therapies through the Prevention of Adipogenesis--Australia
    • A Pan Peroxisome Proliferator-Activated Receptor Agonist Burns Fat--India
    • Cannabinoid Receptor Antagonist Drug Therapy for Obesity and Related Disorders--India
    • A Potential Antiobesity Drug Inhibits Alpha-Amylase--India
  • Technology Innovations in Universities--World
    • Hormone Discovery Offers Hope for Obesity Drug--USA
    • Stomach Hormone Controls Appetite--UK
    • Study Finds Effect of Dietary Calcium on Weightloss--Denmark
    • Research Finds Relationship between Metabolism and Appetite Suppression--Australia
    • Study Shows the Effect of Second Messenger Molecule on Satiety--UK

5 PATENTS AND KEY CONTACTS

  • Patents
    • US Patents--2006
    • US Patents--2004 to 2005
  • Key Contacts
    • Company Contacts
    • University Contacts

6 FROST AND SULLIVAN 2006 SCIENCE AND TECHNOLOGY AWARDS

  • Excellence in Technology Award
    • Award Description
    • Award Recipient
  • Product Innovation Award
    • Award Description
    • Award Recipient
  • Excellence in Research Award
    • Award Description
    • Award Recipient

7 DECISION SUPPORT DATABASE

  • Healthcare and Pharmaceutical Expenditure--World
    • Total Healthcare Expenditure--World (1996 to 2006)
    • Government Healthcare Expenditure--World (1996 to 2006)
    • Private Healthcare Expenditure--World (1996 to 2006)
    • Pharmaceutical R&D Expenditure--World (1996 to 2006)
  • Healthcare Infrastructure--World
    • No. of Hospitals--World (1996 to 2006)
    • No. of Physicians--World (1996 to 2006)
    • No. of Pharmacists--World (1996 to 2006)
  • Pervalence of Obesity-Related Health Risks--World
    • Prevalence of Diabetes--World (1996 to 2006)
    • Prevalence of Hypertension--World (1996 to 2006)
    • Incidence of Stroke--World (1996 to 2006)
    • Prevalence of Coronary Heart Disease--World (1996 to 2006)
Back to Top